Journal of Molecular Neuroscience

, Volume 10, Issue 3, pp 163–179

Advances in the molecular characterization of tryptophan hydroxylase

  • Susan M. Mockus
  • Kent E. Vrana
Minireview

DOI: 10.1007/BF02761772

Cite this article as:
Mockus, S.M. & Vrana, K.E. J Mol Neurosci (1998) 10: 163. doi:10.1007/BF02761772

Abstract

The neurotransmitter serotonin has been implicated in numerous physiological functions and pathophysiological disorders. The hydroxylation of the aromatic amino acid tryptophan is rate-limiting in the synthesis of serotonin. Tryptophan hydroxylase (TPH), as the rate-limiting enzyme, determines the concentrations of serotonin in vivo. Relative serotonin concentrations are clearly important in neural transmission, but serotonin has also been reported to function as a local antioxidant. Identification of the mechanisms regulating TPH activity has been hindered by its low levels in tissues and the instability of the enzyme. Several TPH expression systems have been developed to circumvent these problems. In addition, eukaryotic expressions systems are currently being developed and represent a new avenue of research for identifying TPH regulatory mechanisms. Recombinant DNA technology has enabled the synthesis of TPH deletions, chimeras, and point mutations that have served as tools for identifying structural and functional domains within TPH. Notably, the experiments have proven long-held hypotheses that TPH is organized intoN-terminal regulatory and C-terminal catalytic domains, that serine-58 is a site for PKA-mediated phosphorylation, and that a C-terminal leucine zipper is involved in formation of the tetrameric holoenzyme. Several new findings have also emerged regarding regulation of TPH activity by posttranslational phosphorylation, kinetic inhibition, and covalent modification. Inhibition of TPH byl-DOPA may have implications for depression in Parkinson’s disease (PD) patients. In addition, TPH inactivation by nitric oxide may be involved in amphetamine-induced toxicity. These regulatory concepts, in conjunction with new systems for studying TPH activity, are the focus of this article.

Index Entries

Tryptophan hydroxylaseregulationserotoninphosphorylationnitric oxidebiogenic aminesl-DOPA

Copyright information

© Humana Press Inc. 1998

Authors and Affiliations

  • Susan M. Mockus
    • 1
  • Kent E. Vrana
    • 2
  1. 1.Program in Neuroscience and Department of Physiology and PharmacologyWake Forest University School of MedicineWinston-Salem
  2. 2.Center for the Neurobiological Investigation of Drug Abuse, Department of Physiology and PharmacologyWake Forest University School of MedicineWinston-Salem